FDA clears Advanced Medical’s new wound closure tech
This article was originally published in Clinica
The US FDA has granted 510(k) approval for the latest product in the LiquiBand range developed by Advanced Medical Solutions (AMS). The topical skin adhesive is designed to close and protect surgical incisions in the operating room, and could provide an alternative to sutures and staples. The adhesive is particularly suited to use during laparoscopic procedures, Winsford, UK-based AMS says. The product has a dual applicator which allows initial closure of the surgical incision, followed by the application of an adhesive film to help protect the wound site from infection or breakdown. AMS launched its first LiquiBand product in the US in October 2009, for use on trauma-induced lacerations, minor wounds and laparoscopic skin incisions.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.